In vitro and in vivo efficacy of Molnupiravir against Zika virus infections

Abstract

Electronic Supplementary Material

10.1016j.virs.2023.05.011-ESM.docx

References

1. Barzon, L., Pacenti, M., Franchin, E., Lavezzo, E., Trevisan, M., Sgarabotto, D., Palù, G., 2016. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro surveillance. 21, 30316.
   

2. Bluemling, G.R., Mao, S., Natchus, M.G., Painter, W., Mulangu, S., Lockwood, M., De La Rosa, A., Brasel, T., Comer, J.E., Freiberg, A.N., Kolykhalov, A.A., Painter, G.R., 2022. The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N(4)-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection. Antiviral research. 209, 105453.
   

3. Cugola, F.R., Fernandes, I.R., Russo, F.B., Freitas, B.C., Dias, J.L., Guimarães, K.P., Benazzato, C., Almeida, N., Pignatari, G.C., Romero, S., Polonio, C.M., Cunha, I., Freitas, C.L., Brandão, W.N., Rossato, C., Andrade, D.G., Faria Dde, P., Garcez, A.T., Buchpigel, C.A., Braconi, C.T., Mendes, E., Sall, A.A., Zanotto, P.M., Peron, J.P., Muotri, A.R., Beltrão-Braga, P.C., 2016. The Brazilian Zika virus strain causes birth defects in experimental models. Nature. 534, 267-271.
   

4. Faye, O., Freire, C.C., Iamarino, A., Faye, O., de Oliveira, J.V., Diallo, M., Zanotto, P.M., Sall, A.A., 2014. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS neglected tropical diseases. 8, e2636.
   

5. Lessler, J., Chaisson, L.H., Kucirka, L.M., Bi, Q., Grantz, K., Salje, H., Carcelen, A.C., Ott, C.T., Sheffield, J.S., Ferguson, N.M., Cummings, D.A., Metcalf, C.J., Rodriguez-Barraquer, I., 2016. Assessing the global threat from Zika virus. Science. 353, aaf8160.
   

6. Li, J.Q., Deng, C.L., Gu, D., Li, X., Shi, L., He, J., Zhang, Q.Y., Zhang, B., Ye, H.Q., 2018. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus. Antiviral research. 150, 148-154.
   

7. Li, Y., Liu, M., Yan, Y., Wang, Z., Dai, Q., Yang, X., Guo, X., Li, W., Chen, X., Cao, R., Zhong, W., 2022. Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo. Viruses. 14, 1142.
   

8. Nicastri, E., Castilletti, C., Liuzzi, G., Iannetta, M., Capobianchi, M.R., Ippolito, G., 2016. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro surveillance. 21, 30314.
   

9. Nie, Y., Hui, L., Guo, M., Yang, W., Huang, R., Chen, J., Wen, X., Zhao, M., Wu, Y., 2021. Rearrangement of Actin Cytoskeleton by Zika Virus Infection Facilitates Blood-Testis Barrier Hyperpermeability. Virologica Sinica 36, 692-705.
   

10. Pacheco, O., Beltrán, M., Nelson, C.A., Valencia, D., Tolosa, N., Farr, S.L., Padilla, A.V., Tong, V.T., Cuevas, E.L., Espinosa-Bode, A., Pardo, L., Rico, A., Reefhuis, J., González, M., Mercado, M., Chaparro, P., Martínez Duran, M., Rao, C.Y., Muñoz, M.M., Powers, A.M., Cuéllar, C., Helfand, R., Huguett, C., Jamieson, D.J., Honein, M.A., Ospina Martínez, M.L., 2020. Zika Virus Disease in Colombia-Preliminary Report. The New England journal of medicine. 383, e44.
    

11. Rosenke, K., Okumura, A., Lewis, M.C., Feldmann, F., Meade-White, K., Bohler, W.F., Griffin, A., Rosenke, R., Shaia, C., Jarvis, M.A., Feldmann, H., 2022. Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. JCI insight. 7, e160108.
    

12. Sargent, K., Mollard, J., Henley, S.F., Bollasina, M.A., 2022. Predicting Transmission Suitability of Mosquito-Borne Diseases under Climate Change to Underpin Decision Making. International journal of environmental research and public health. 19, 13656.
    

13. Toots, M., Yoon, J.J., Cox, R.M., Hart, M., Sticher, Z.M., Makhsous, N., Plesker, R., Barrena, A.H., Reddy, P.G., Mitchell, D.G., Shean, R.C., Bluemling, G.R., Kolykhalov, A.A., Greninger, A.L., Natchus, M.G., Painter, G.R., Plemper, R.K., 2019. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Science translational medicine. 11, eaax5866.
    

14. Voordouw, B., Rockx, B., Jaenisch, T., Fraaij, P., Mayaud, P., Vossen, A., Koopmans, M., 2019. Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays. Clinical microbiology reviews. 33, e00130-18.
    

15. Wang, H., Li, Z., Niu, J., Xu, Y., Ma, L., Lu, A., Wang, X., Qian, Z., Huang, Z., Jin, X., Leng, Q., Wang, J., Zhong, J., Sun, B., Meng, G., 2018. Antiviral effects of ferric ammonium citrate. Cell discovery 4, 14.
    

16. Wang, Q., Cao, R., Li, L., Liu, J., Yang, J., Li, W., Yan, L., Wang, Y., Yan, Y., Li, J., Deng, F., Zhou, Y., Wang, M., Zhong, W., Hu, Z., 2022a. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean-Congo hemorrhagic fever virus. Antiviral research. 199, 105273.
    

17. Wang, Z., Yan, Y., Dai, Q., Xu, Y., Yin, J., Li, W., Li, Y., Yang, X., Guo, X., Liu, M., Chen, X., Cao, R., Zhong, W., 2022b. Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp. Viruses. 14, 1228.
    

18. WHO, 2022. Zika epidemiology update-February 2022. https://www.who.int/publications/m/item/zika-epidemiology-update-february-2022 (Accessed 21 April 2023)
    

19. Wikan, N., Smith, D.R., 2016. Zika virus:history of a newly emerging arbovirus. The Lancet. Infectious diseases. 16, e119-e126.
    

20. Yan, Y., Yang, J., Xiao, D., Yin, J., Song, M., Xu, Y., Zhao, L., Dai, Q., Li, Y., Wang, C., Wang, Z., Ren, X., Yang, X., Ni, J., Liu, M., Guo, X., Li, W., Chen, X., Liu, Z., Cao, R., Zhong, W., 2022. Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins. Antiviral research. 202, 105325.
    

21. Yang, J., Yan, Y., Dai, Q., Yin, J., Zhao, L., Li, Y., Li, W., Zhong, W., Cao, R., Li, S., 2022. Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus. Virologica Sinica. 37, 145-148.
    

Proportional views